308 filings
8-K
IONS
Ionis Pharmaceuticals Inc
29 Feb 24
Entry into a Material Definitive Agreement
9:10am
8-K
IONS
Ionis Pharmaceuticals Inc
21 Feb 24
Ionis reports fourth quarter and full year 2023 financial results
11:17am
8-K
IONS
Ionis Pharmaceuticals Inc
22 Jan 24
Ionis announces positive topline results from Phase 3 OASIS-HAE study of investigational donidalorsen in patients with hereditary angioedema
7:10am
8-K
IONS
Ionis Pharmaceuticals Inc
21 Dec 23
Other Events
8:27pm
8-K
IONS
Ionis Pharmaceuticals Inc
18 Dec 23
Ionis announces European licensing agreement with Otsuka for donidalorsen in hereditary angioedema
4:11pm
8-K
ykckg6rmq1m vg79vntk
14 Dec 23
Ionis announces the appointment of Michael Yang to Board of Directors
4:10pm
8-K
hqha8o v1kcd
2 Nov 23
Ionis reports third quarter 2023 financial results
11:15am
8-K
ukyjc3msh 1vxo
27 Sep 23
Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer’s disease and Huntington’s disease
7:05am
8-K
p7ggzhqyrd6288fibn
26 Sep 23
Ionis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndrome
7:05am
8-K
xp1z7jwc
23 Aug 23
Other Events
5:14pm
8-K
hdyre gtf52bs
21 Aug 23
Other Events
7:05pm
8-K
gy2wc
9 Aug 23
Ionis reports second quarter 2023 financial results
11:15am
8-K
h9l7fo0f3
4 Aug 23
Termination of a Material Definitive Agreement
4:30pm
8-K
yjsmdxnjfzxss
3 Aug 23
Entry into a Material Definitive Agreement
4:30pm
8-K
x64 vdxb44
10 Jul 23
Eplontersen continued to show improvement in ATTRv-PN through 85 weeks
7:00am
8-K
ugpk4pz7t41 uix5bg
12 Jun 23
Ionis prices private placement of convertible senior notes
4:03pm
8-K
hdag79t
6 Jun 23
Ionis announces proposed private placement
4:12pm
8-K
l1dw8bj2mc a2coul
5 Jun 23
Submission of Matters to a Vote of Security Holders
10:56am
8-K
ci5tpmip3c3gpyqpord
3 May 23
Ionis reports first quarter 2023 financial results
11:15am
8-K
3wsypf5r0q87fde
25 Apr 23
FDA approves QALSODY™ (tofersen) as the first treatment targeting a genetic cause of ALS
8:40pm